Archive

Browse hundreds of free full-text articles and clinical supplements, or search for specific issues related to psychiatry and primary practice.

Recent Articles

  Funding for this supplement has been provided by Forest Pharmaceuticals, Inc.   Dr. Schatzberg is Kenneth T. Norris, Jr. Professor and Chairman of psychiatry and behavioral science at Stanford University School of Medicine in California. Disclosures: Dr. Schatzberg is a consultant to Abbott, Bristol-Myers Squibb, Corcept, Eli Lilly, Forest, Merck, NeuroPharmaBoost, Roche, Synosis, and…
Read >

  This supplement is supported by Pamlab LLC. Dr. Cummings is director of the Mary S. Easton Center of Alzheimer’s Disease Research in the Departments of Neurology and Psychiatry and Behavioral Sciences, David Geffen School of Medicine, at the University of California, Los Angeles. Disclosure: Dr. Cummings has provided consultation to Abbott, Acadia, Accera, ADAMAS,…
Read >

  Question & Answer Forum The following question-and-answer session was prepared from a discussion with Roger S. McIntyre, MD, FRCPC, moderated by Diane M. Sloan, PharmD, of Advogent. Acknowledgments: The authors acknowledge Dennis Stancavish, MA, and Jennifer Hutcheson, BA, of Advogent, for assistance in the preparation of this manuscript. This question-and-answer session was supported by…
Read >

  This supplement is supported by Pamlab LLC.   Question-and-Answer Session Q: Studies are showing that treatment initiated when pre-dementia or early memory loss is recognized leads to a better prognosis than waiting to initiate treatment once Alzheimer’s disease (AD) or dementia is established. What options do clinicians have to address early memory loss?  …
Read >

  This supplement is supported by Pamlab LLC. Dr. McCaddon is senior honorary research fellow at Cardiff University, Cardiff School of Medicine, in North Wales, United Kingdom. Dr. Hudson is principal biochemist in the Department of Medical Biochemistry, Wrexham Maelor Hospital, in North Wales, United Kingdom. Disclosures: Drs. McCaddon and Hudson are scientific advisors and…
Read >

Clinical Supplement Back to Clinical Supplements Print Friendly  Management of Painful Physical Symptoms Associated With Depression and Mood Disorders Moderator: Thomas N. Wise, MD; Discussants: Lesley M. Arnold, MD, Vladimir Maletic, MD; Section Editor: David L. Ginsberg, MD Return   Primary Psychiatry. 2005;12(11 suppl 10):1-16. Funding for this roundtable monograph supplement has been provided through…
Read >

Clinical Supplement Back to Clinical Supplements Print Friendly  Depression in the Elderly: The Unique Features Related to Diagnosis and Treatment Moderator: Katherine Shear, MD; Section editor: David L. Ginsberg, MD; Discussants: Steven P. Roose, MD, Eric J. Lenze, MD, George S. Alexopoulos, MD; CME Reviewer: Eric Hollander, MD Return Primary Psychiatry. 2006;12(8 suppl 7):1-16.  …
Read >

Clinical Supplement Back to Clinical Supplements Print Friendly  Pediatric ADHD: Clinical Criteria for Diagnosis and Management Timothy E. Wilens, MD; Floyd R. Sallee, MD, PhD, Dennis J. Rosen, MD James M. Swanson, PhD, James McGough, MD Michael J. Manos, PhD Moderator: Peter L. Salgo, MD Section editor: David L. Ginsberg, MD Return  Primary Psychiatry. 2004;11(2):1-10…
Read >

Clinical Supplement Back to Clinical Supplements Print Friendly  Long-Term Issues in the Treatment of Sleep Disorders Thomas Roth, PhD, Andrew D. Krystal, MD, MS, and Joseph A. Lieberman III, MD, MPH Return  Primary Psychiatry. 2007;14(7 suppl 5):1-16 This clinical supplement is supported by funding from Takeda Pharmaceuticals North America An expert panel review of clinical…
Read >

Column Print Friendly  Weight Issues in Schizophrenia Anita H. Clayton, MD Return Primary Psychiatry. 2006;13(3):22-24   Dr. Clayton is professor of psychiatric medicine at the University of Virginia in Charlottesville.   Disclosure: Dr. Clayton is a consultant to and on the advisory boards of Boehringer-Ingelheim, Eli Lilly, GlaxoSmithKline, Pfizer, Vela, and Wyeth; is on the…
Read >